Product Information
SILDENAFIL 10 MG/ML ORAL SUSP is a generic product labeled by Virtus Pharmaceuticals, LLC, priced at $0.6131 per ML under NDC 69543041972. Its NADAC has been published 42 times since Apr 17, 2024.
FDA first approved this application on Apr 29, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the sildenafil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/mL
Manufacturer
Virtus Pharmaceuticals, LLCNDC
69543041972
Classification
Generic
Dosage Form
FOR SUSPENSION
Route
ORAL
Effective Date
1/22/2025
Active Ingredients
SILDENAFIL CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA213814FDA Approved
4/29/2021
TE Code
AB
On Market Since
8/2/2021
Pharmacological Classes
Price Statistics
The NADAC for SILDENAFIL 10 MG/ML ORAL SUSP has been published 42 times since Apr 17, 2024, and over the history we have for it it has declined 22.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6131 per ML |
|---|---|
| All-time high | $0.7945 (May 15, 2024) |
| All-time low | $0.5834 (Nov 20, 2024) |
| Median price | $0.6925 |
| Average price | $0.6819 |
| Largest weekly change | -10.2% (Nov 20, 2024) |
| Weeks tracked | 42 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-22.8%
Last surveyed Jan 29, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the sildenafil market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Virtus Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sildenafil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 5 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SILDENAFIL 10 MG/ML ORAL SUSP?
The current National Average Drug Acquisition Cost (NADAC) for SILDENAFIL 10 MG/ML ORAL SUSP, manufactured by Virtus Pharmaceuticals, LLC, is $0.6131 per ML (NDC 69543041972), effective Jan 29, 2025.
How has the price of SILDENAFIL 10 MG/ML ORAL SUSP changed over time?
Over the history we have for it, the NADAC for SILDENAFIL 10 MG/ML ORAL SUSP has declined 22.8%. It has been tracked across 42 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for SILDENAFIL 10 MG/ML ORAL SUSP?
Since Apr 17, 2024, the NADAC for SILDENAFIL 10 MG/ML ORAL SUSP has ranged from a low of $0.5834 (Nov 20, 2024) to a high of $0.7945 (May 15, 2024), with a median of $0.6925 per ML.
Are there cheaper alternatives to SILDENAFIL 10 MG/ML ORAL SUSP?
No other NADAC-published product currently shares the active ingredient and strength of SILDENAFIL 10 MG/ML ORAL SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SILDENAFIL 10 MG/ML ORAL SUSP?
SILDENAFIL 10 MG/ML ORAL SUSP (NDC 69543041972) is labeled by Virtus Pharmaceuticals, LLC, and CMS classifies it as a generic product.